Skip Navigation

This Article
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (32)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Glander, H.-J.
Right arrow Articles by Birkenmeier, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glander, H.-J.
Right arrow Articles by Birkenmeier, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 11, No. 11, pp. 2454-2460, 1996
© 1996 European Society of Human Reproduction and Embryology


research-article

Andrology: Insulin-like growth factor-I and {alpha}2-macroglobulin in seminal plasma correlate with semen quality

H.-J. Glander1,1, J. Kratzsch2, Ch. Weisbrich2 and G. Birkenmeier3

1Department of Dermatology, Andrological Unit Liebigstrasse 21, D-04103 Leipzig, Germany 2Department of Clinical Chemistry and Pathological Biochemistry Liebigstrasse 21, D-04103 Leipzig, Germany 3Department of Biochemistry, University of Leipzig Liebigstrasse 21, D-04103 Leipzig, Germany

Correspondence: 1To whom correspondence should be addressed

Insulin-like growth factor-I (IGF-I) and {alpha}2-macroglobulin ({alpha}2-M) are believed to be involved in the development of germ cells. IGF-I is mainly controlled by concentrations of human growth hormone (HGH), influences cell proliferation and differentiation and its action is mediated by insulin-like growth factor-binding proteins (IGFBP), placental protein 14 (PP14) and prostate-specific antigen (PSA). {alpha}2-M acts as a broad spectrum proteinase inhibitor and a binding protein for many cytokines and hormones, e.g. inhibin and activin. This study was designed to identify concentrations of these molecules in seminal plasma in normal semen samples of healthy men, correlations with semen quality, the relationship of IGF-I and {alpha}2-M with factors affecting male fertility, and whether vasectomy influences the concentrations of these molecules. Concentrations of IGF-I and{alpha}2-M in human seminal plasma were related to semen quality, basal concentrations of HGH, testosterone, IGFBP-3, soluble fibronectin receptor (sFNR), PSA and PP14 in seminal plasma and to serum concentrations of luteinizing hormone (LH) and follicle stimulating hormone (FSH). Commercially available assays were used to analyse 69 semen samples of various quality and 11 post-vasectomy samples. IGF-I concentrations in seminal plasma were significantly correlated with the percentage of morphologically normal spermatozoa (r = 0.748, P = 0.00001) and sperm concentration (r = 0301, P = 0.011), but negatively correlated with serum FSH (r = –0.506, P = 0.00006) and PSA in seminal plasma (r = –0388, P = 0.0009). Total {alpha}2-M was significantly correlated with sperm count (r = 0.423, P = 0.0005), percentage of progressively motile spermatozoa (r = 0.444, P = 0.00019), quality of motility (sperm motile efficiency, r = 802, P = 0.00001) and straight line velocity (r = 0.411, P = 0.0013). Correlation between the sperm concentration and HGH in seminal plasma was weak (r = 0.287, P = 0.015). Vasectomy reduced the concentration of total {alpha}2-M (P = 0.00008) and HGH (P = 0.0068) in the seminal plasma; IGF-I was also reduced after vasectomy when the total ejaculate amount was considered. Thus IGF-I and {alpha}2-M are significant for the germ cell development: IGF-I hi the maturation of spermatozoa and {alpha}2-M in progressive motility.

Key words: insulin-like growth factor-I/{alpha}2-macroglobulin/seminal plasma/spenniogram parameters/vasectomy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Poult. Sci.Home page
J. X. Zheng, Z. Z. Liu, and N. Yang
Deficiency of Growth Hormone Receptor Does Not Affect Male Reproduction in Dwarf Chickens
Poult. Sci., January 1, 2007; 86(1): 112 - 117.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
R. K. Naz and R. Sellamuthu
Receptors in Spermatozoa: Are They Real?
J Androl, September 1, 2006; 27(5): 627 - 636.
[Full Text] [PDF]


Home page
J ANIM SCIHome page
A. Yilmaz, M. E. Davis, and R. C. M. Simmen
Estimation of (co)variance components for reproductive traits in Angus beef cattle divergently selected for blood serum IGF-I concentration
J Anim Sci, August 1, 2004; 82(8): 2285 - 2292.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
M.L. Macpherson, R.C.M. Simmen, F.A. Simmen, J. Hernandez, B.R. Sheerin, D.D. Varner, P. Loomis, M.E. Cadario, C.D. Miller, S.P. Brinsko, et al.
Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-2 and -5 in Equine Seminal Plasma: Association with Sperm Characteristics and Fertility
Biol Reprod, August 1, 2002; 67(2): 648 - 654.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. Fenichel, R. Rey, S. Poggioli, M. Donzeau, D. Chevallier, and G. Pointis
Anti-Mullerian hormone as a seminal marker for spermatogenesis in non-obstructive azoospermia
Hum. Reprod., August 1, 1999; 14(8): 2020 - 2024.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
B. Loras, F. Vetele, A. E. Malki, J. Rollet, J.-C. Soufir, and M. Benahmed
Seminal transforming growth factor-ß in normal and infertile men
Hum. Reprod., June 1, 1999; 14(6): 1534 - 1539.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.